10 completed, 5 recruiting, 1 active not recruiting, 1 withdrawn. 17 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 17 | Completed 10, Recruiting 5, Active not recruiting 1, Withdrawn 1 |
Follow Type 2 Diabetes: new trials by email Literature Review of Type 2 Diabetes trials Research Report on Type 2 Diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SMART 2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in Adolescents and Young Adults With Type 2 Diabetes Montelukast, Montelukast Placebo - Type 2 Diabetes | Early Phase 1 | Recruiting | University of Colorado, Denver | 50 | 2026-10-12 | 2026-10-06 |
| SGLT2i, Hepatic Glucose Production, and SNS Empagliflozin 25 MG - Type 2 Diabetes | Early Phase 1 | Recruiting | The University of Texas Health Science Center at San Antonio | 22 | 2025-01-07 | 2026-07-17 |
| Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease Oral sodium suppression test, Saline suppression test, Captopril suppression test - Type 2 Diabetes, Chronic Kidney Diseases | Early Phase 1 | Active not recruiting | Brigham and Women's Hospital | 125 | 2024-05-15 | 2026-08-13 |
| Precision Dosing of Metformin in Youth With T2D Metformin - Type 2 Diabetes | Early Phase 1 | Recruiting | University of California, San Francisco | 20 | 2024-04-25 | 2025-12-23 |
| Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes Ketone Monoester (KE) - Type 2 Diabetes, Heart Failure, Reduced Ejection Fraction | Early Phase 1 | Recruiting | The University of Texas Health Science Center at San Antonio | 10 | 2024-01-16 | 2026-01-21 |
| Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction Trehalose, Placebo - Type 2 Diabetes, Healthy Aging | Early Phase 1 | Recruiting | Medical College of Wisconsin | 60 | 2023-01-01 | 2025-10-30 |
| Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM REMD-477, Placebo Subcutaneous injection - Type 2 Diabetes, Glucose Tolerance Impaired | Early Phase 1 | Completed | The University of Texas Health Science Center at San Antonio | 4 | 2021-11-10 | 2024-08-09 |
| Ertugliflozin: Cardioprotective Effects on Epicardial Fat Ertugliflozin - Cardiovascular Diseases, Atherosclerosis | Early Phase 1 | Completed | Stanford University | 61 | 2020-07-01 | 2026-06-04 |
| Liver-enriched Antimicrobial Peptide 2 Liver-enriched antimicrobial peptide 2, Placebo - Type 2 Diabetes | Early Phase 1 | Completed | University Hospital, Gentofte, Copenhagen | 10 | 2019-01-28 | 2021-05-26 |
| Effects of DPP-4 Inhibition on Calcium and Bone Metabolism in Type 2 Diabetes Mellitus Sitagliptin - Type 2 Diabetes | Early Phase 1 | Withdrawn | University of Missouri-Columbia | 2015-05-01 | 2017-06-01 | |
| Dietary Supplement of LEHEL for the Patients With Type 2 Diabetes LEHEL multi-nutrients supplement - Type 2 Diabetes | Early Phase 1 | Completed | Shaoguan University | 71 | 2013-06-01 | 2014-05-12 |
| Pilot Study of the Effect of MN-504 Cobiotic Formulation on the Efficacy and Tolerability of Metformin NM504 - Type 2 Diabetes | Early Phase 1 | Completed | NuMe Health | 10 | 2013-05-01 | 2014-07-24 |
| Metabolic Control Before and After Supplementation With Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes Patients Lactobacillus reuteri DSM 17938 - Type 2 Diabetes, Insulin Resistance | Early Phase 1 | Completed | Vastra Gotaland Region | 12 | 2012-05-01 | 2020-02-12 |
| Self-management in Type 2 Diabetes Patients Using the Few Touch Application Use of Few Touch Application (FTA), Use of FTA and health counseling based on TTM and CBT - Type 2 Diabetes | Early Phase 1 | Completed | University Hospital of North Norway | 151 | 2011-03-01 | 2014-12-12 |
| Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus euinsulinemic euglycemic glucose clamp, euinsulinemic hyperglycemic glucose clamp, Hyperinsulinemic euglycemic glucose clamp - Type 2 Diabetes | Early Phase 1 | Completed | University of Maryland, Baltimore | 31 | 2009-07-01 | 2019-09-12 |
| Antioxidant Treatment of Type 2 Diabetes Placebo, n-aceylcysteine - Type 2 Diabetes | Early Phase 1 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 44 | 2008-07-01 | 2014-12-24 |
| Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4 Hyperinsulinemic Hypoglycemic Clamp - Type 2 Diabetes | Early Phase 1 | Completed | University of Maryland, Baltimore | 20 | 2007-05-01 | 2019-09-12 |
Diabetes Mellitus, Type 2 (17) · Diabetes Mellitus (3) · Insulin Resistance (3) · Atherosclerosis (1) · Bone Diseases, Metabolic (1) · Cardiovascular Diseases (1) · Glucose Intolerance (1) · Heart Failure, Systolic (1) · Hypoglycemia (1) · Inflammation (1) · Malnutrition (1) · Metabolic Diseases (1) · Renal Insufficiency, Chronic (1)
Endocrine System Diseases (17) · Glucose Metabolism Disorders (17) · Nutritional and Metabolic Diseases (17) · Metabolic Diseases (16) · Diabetes Mellitus (14) · Hyperinsulinism (3) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Bone Diseases (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1)
Metformin (1) · Sitagliptin Phosphate (1) · Sodium-Glucose Transporter 2 Inhibitors (1) · Trehalose (1) · empagliflozin (1) · ertugliflozin (1) · montelukast (1) · rVSV-deltaG-spike COVID-19 vaccine (1) · soybean oil, phospholipid emulsion (1) · volagidemab (1)
The University of Texas Health Science Center at San Antonio (3) · University of Maryland, Baltimore (2) · Brigham and Women's Hospital (1) · Medical College of Wisconsin (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · NuMe Health (1) · Shaoguan University (1) · Stanford University (1) · University Hospital of North Norway (1) · University Hospital, Gentofte, Copenhagen (1) · University of California, San Francisco (1) · University of Colorado, Denver (1) · University of Missouri-Columbia (1) · Vastra Gotaland Region (1)
United States (13) · China (1) · Denmark (1) · Norway (1) · Sweden (1)
Ralph DeFronzo, MD (2) · Stephen N. Davis, MD (2) · Carolina Solis-Herrera, MD (1) · Filip K Knop, MD, PhD (1) · Muhammed T Sarmini, MD (1) · Shylaja Srinivasan, MD (1) · Tracey McLaughlin, MD (1) · Wenhua Ling, Ph.D. (1) · William Hughes, Ph.D. (1)
PMID 20587723, PMID 23978690, PMID 25695946, PMID 27239317, PMID 29784635, PMID 31492176
1UM1TR004538-01 (1), K23DK120932 (1), R01DK024092 (1)